Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccc.2015.10.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preface: Emergency obstetrics in low- and middle-income countries.
Best Pract Res Clin Obstet Gynaecol
December 2024
Women's Health and HIV Research Group, Department of Obstetrics and Gynecology, School of Clinical Medicine, Faculty of Health Sciences, University of Kwa Zulu-Natal, Durban, South Africa. Electronic address:
Surgical treatment of endometriosis - Controversies: Preface.
Best Pract Res Clin Obstet Gynaecol
December 2024
Department of Obstetrics and Gynecology, Gynecology Oncology and Minimally-Invasive Pelvic Surgery, International School of Surgical Anatomy (ISSA), IRCCS Ospedale Sacro Cuore - Don Calabria, Via Don A. Sempreboni 5, 37024, Negrar Verona, Italy; Unit of Obstetrics and Gynecology, P.O. "Ospedale del Tigullio"-ASL4, Via Gio Batta Ghio 9, 16043, Chiavari, Genoa, Italy. Electronic address:
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Eur J Cancer
September 2024
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
Background: The monarchE and NATALEE trials demonstrated the benefit of CDK4/6 inhibitor (CDK4/6i) therapy in adjuvant breast cancer (BC) treatment. Patient selection, based on clinical characteristics, delineated those at high (monarchE) and high/intermediate recurrence risk (NATALEE). This study employed a historical patient cohort to describe the proportion and prognosis of patients eligible for adjuvant CDK4/6i trials.
View Article and Find Full Text PDFCorrection: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Geburtshilfe Frauenheilkd
February 2024
Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Article Synopsis
- The text discusses a necessary correction to a previously published article identified by the DOI 10.1055/a-2238-3153.
- It highlights the importance of accuracy in scientific publications and the impact of corrections on the integrity of research.
- This rectification ensures that readers and researchers rely on correct information when referencing the work.
Preface to the special issue of "Regenerative therapy": "Future of regenerative medicine viewed by young scientists".
Regen Ther
June 2024
Department of Pediatric Surgery, Fukushima Medical University Hospital, Fukushima-shi, Fukushima 960-1295, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!